Aparna Pharmaceuticals

Hyderabad, India Founded: 2008 • Age: 18 yrs
API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO.
Request Access

About Aparna Pharmaceuticals

Aparna Pharmaceuticals is a company based in Hyderabad (India) founded in 2008 by Rakesh Reddy.. Aparna Pharmaceuticals has raised $674.33 thousand across 2 funding rounds from investors including Loven Labs and Care Ind Chem. The company has 1 employees as of March 28, 2024. Aparna Pharmaceuticals offers products and services including Active Pharmaceutical Ingredients, Intermediates, and Contract Manufacturing. Aparna Pharmaceuticals operates in a competitive market with competitors including Viyash, Inventys, Blue Jet Healthcare, Ami organics and DUDE CHEM, among others.

  • Headquarter Hyderabad, India
  • Employees 1 as on 28 Mar, 2024
  • Founders Rakesh Reddy
  • Stage Minicorn
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aparna Pharmaceuticals Private Limited
  • Date of Incorporation 01 Sep, 2020
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $7.99 M (USD)
    121.37
    as on Mar 31, 2024
  • Net Profit
    $-12.99 M (USD)
    -4545.03
    as on Mar 31, 2024
  • EBITDA
    $-8.06 M (USD)
    -2793.83
    as on Mar 31, 2024
  • Total Equity Funding
    $674.33 K (USD)

    in 2 rounds

  • Latest Funding Round
    $224.91 K (USD), Seed

    Mar 11, 2017

  • Investors
    Loven Labs

    & 1 more

  • Employee Count
    1

    as on Mar 28, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Aparna Pharmaceuticals

Aparna Pharmaceuticals offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Intermediates, and Contract Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Production of APIs for global pharmaceutical markets

Supply of high-quality intermediates for drug manufacturing

Custom services for pharmaceutical production needs

Funding Insights of Aparna Pharmaceuticals

Aparna Pharmaceuticals has successfully raised a total of $674.33K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $224.91 thousand completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $224,907
  • First Round

    (12 Oct 2016)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2017 Amount Seed - Aparna Pharmaceuticals Valuation Loven Labs
Oct, 2016 Amount Seed - Aparna Pharmaceuticals Valuation Care Ind Chem
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Aparna Pharmaceuticals

Aparna Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Loven Labs and Care Ind Chem. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Basic chemicals are manufactured by Loven Labs in Hyderabad, India.
Founded Year Domain Location
Basic chemicals are manufactured in Hyderabad, India.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Aparna Pharmaceuticals

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Aparna Pharmaceuticals

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aparna Pharmaceuticals Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aparna Pharmaceuticals

Aparna Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viyash, Inventys, Blue Jet Healthcare, Ami organics and DUDE CHEM, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
APIs and intermediates are manufactured by Viyash as a CDMO.
domain founded_year HQ Location
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
domain founded_year HQ Location
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
domain founded_year HQ Location
Advanced API intermediates are manufactured for pharmaceutical use.
domain founded_year HQ Location
CDMO focused on manufacturing of APIs and intermediates
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aparna Pharmaceuticals

Frequently Asked Questions about Aparna Pharmaceuticals

When was Aparna Pharmaceuticals founded?

Aparna Pharmaceuticals was founded in 2008 and raised its 1st funding round 8 years after it was founded.

Where is Aparna Pharmaceuticals located?

Aparna Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Is Aparna Pharmaceuticals a funded company?

Aparna Pharmaceuticals is a funded company, having raised a total of $674.33K across 2 funding rounds to date. The company's 1st funding round was a Seed of $449.42K, raised on Oct 12, 2016.

How many employees does Aparna Pharmaceuticals have?

As of Mar 28, 2024, the latest employee count at Aparna Pharmaceuticals is 1.

What is the annual revenue of Aparna Pharmaceuticals?

Annual revenue of Aparna Pharmaceuticals is $7.99M as on Mar 31, 2024.

What does Aparna Pharmaceuticals do?

Aparna Pharmaceuticals was established in 2008 in Hyderabad, India, and functions as a contract development and manufacturing organization within the pharmaceutical sector. Focus is placed on the production of active pharmaceutical ingredient intermediates. Operations are centered in India, with leadership provided by founder and director Rakesh Reddy. Services encompass manufacturing processes tailored for API intermediates, supporting pharmaceutical supply chains.

Who are the top competitors of Aparna Pharmaceuticals?

Aparna Pharmaceuticals's top competitors include Inventys, Viyash and Blue Jet Healthcare.

What products or services does Aparna Pharmaceuticals offer?

Aparna Pharmaceuticals offers Active Pharmaceutical Ingredients, Intermediates, and Contract Manufacturing.

Who are Aparna Pharmaceuticals's investors?

Aparna Pharmaceuticals has 2 investors. Key investors include Loven Labs, and Care Ind Chem.

What is Aparna Pharmaceuticals's valuation?

The valuation of Aparna Pharmaceuticals is $4.31M as of Mar 2017.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available